Papers are reviewed on the basis that they do not contain plagiarized material and have not been submitted to any other conference at the same time (double submission). Helix adopts the double blind review process of the submitted papers.

The length of review process varies between papers, and many factors affect the time it takes to review a paper. The time it takes for an associate editor to be assigned, and for available, qualified reviewers to be located, depends on the complexity and the type of material submitted for review. Each publication makes a concerted effort to keep the review time to a minimum that is consistent with keeping the publications reputation for quality and integrity. Each submission placed into review is sent to at least two reviewers.You must indicate the reason for requesting or excluding reviewers during the submission process if any.

Submissions are first evaluated by the Editors and by the members of the Editorial Boards within two weeks. If the manuscript is considered suitable for publication, it is sent to at least two reviewers.

The peer review process is double-blind, whereby both referees and authors are kept anonymous.

Referees are asked to evaluate the manuscript within four weeks. If the reviews are positive, but the manuscript requires to be revised and resubmitted, the author is expected to submit the revised version in four weeks.

Publication decisions by the Editors / Board of Directors are final.

Each Paper is reviewed by 3 reviewers. Meta review is done on case to case basis

ACCEPTANCE RATE
Current Paper acceptance rate of this Journal is around <30%

PAPER SUBMISSION
Submit your papers to the editor at helix@dnares.in

COPYRIGHT
The author is responsible for obtaining copyright releases and corporate and security clearances prior to submitting material for consideration. It is the our policy to assume that all clearances are granted when a paper is submitted. The Helix consent to publish online form must be completed & submitted after notification of acceptance.